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Abstract: miRNA regulates the expression of protein coding genes and plays a regulatory role in
human development and disease. The human iPSCs and their differentiated progenies provide
a unique opportunity to identify these miRNA-mediated regulatory mechanisms. To identify
miRNA–mRNA regulatory interactions in human nervous system development, well characterized
NSCs were differentiated from six validated iPSC lines and analyzed for differentially expressed (DE)
miRNome and transcriptome by RNA sequencing. Following the criteria, moderated t statistics,
FDR-corrected p-value ≤ 0.05 and fold change—absolute (FC-abs) ≥2.0, 51 miRNAs and 4033 mRNAs
were found to be significantly DE between iPSCs and NSCs. The miRNA target prediction analysis
identified 513 interactions between 30 miRNA families (mapped to 51 DE miRNAs) and 456 DE
mRNAs that were paradoxically oppositely expressed. These 513 interactions were highly enriched in
nervous system development functions (154 mRNAs; FDR-adjusted p-value range: 8.06 × 10−15 –1.44
× 10−4 ). Furthermore, we have shown that the upregulated miR-10a-5p, miR-30c-5p, miR23-3p,
miR130a-3p and miR-17-5p miRNA families were predicted to down-regulate several genes associated
with the differentiation of neurons, neurite outgrowth and synapse formation, suggesting their role
in promoting the self-renewal of undifferentiated NSCs. This study also provides a comprehensive
characterization of iPSC-generated NSCs as dorsal neuroepithelium, important for their potential use
in in vitro modeling of human brain development and disease.
Keywords: human; induced pluripotent stem cell; neural stem cell; miRNA; mRNA; gene expression
regulation

1. Introduction
The cell fate determination during embryonic development and adult tissue homeostasis
is orchestrated by global changes in the cellular transcriptome and proteome—a complex but
tightly regulated process involving diverse regulatory mechanisms. MicroRNAs (miRNAs) are
~22-nucleotide-long, noncoding RNAs that regulate the posttranscriptional expression of protein
coding genes [1,2]. The regulatory process typically involves complement base-pairing of the 5-prime
Int. J. Mol. Sci. 2020, 21, 6980; doi:10.3390/ijms21196980
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region of the mature miRNA known as the seed sequence to the 3-prime untranslated region (3’ UTR)
of complementary/partially complementary messenger RNAs (mRNAs). The binding of the miRNA
with cognate mRNAs typically results in either the destabilization or suppressed translation of the
mRNA targets [3,4]. This complementary nature of the miRNA–mRNA interaction is being exploited
to computationally predict and identify miRNAs regulatory targets [5–8].
Like transcription factors, single miRNAs can regulate the expression of numerous genes and a
single protein coding gene can be a target of multiple miRNAs. The miRNAs spatial and temporal
expression is tightly regulated by cellular developmental and physiological state, indicating a key
role that miRNAs play in regulating cell fate and differentiation [3,9]. Complex miRNA regulatory
events are woven into the known transcription factor and signaling networks that control cell fate and
differentiation, modulating their activity through positive and negative feedback loops to reinforce
cellular decisions. However, miRNA expression is highly cell- and tissue-specific [3,10,11].
During embryonic development, pluripotent embryonic stem cells give rise to fate-restricted
multipotent stems cells, which, in response to specific stimuli, can commit to a given cellular fate
while retaining a broad self-renewal potential. Neural stem cells (NSCs) are encountered in both
the embryonic and adult brain and are capable of differentiating into all cell types of the central
nervous system. During development, different intra- and extracellular signals stimulate NSCs to
become neural progenitors, which eventually irreversibly exit the cell cycle to begin the first stage of
neurogenesis. However, before this event occurs, the self-renewal and proliferative capacities of neural
stem cells must be tightly regulated, and miRNAs may play a key role in maintaining the neural stem
cell state as well as in the developmental processes of the nervous system [11].
During the last one and half decades, human embryonic stem cells (ESCs) and human-induced
pluripotent stem cells (iPSCs) in particular, have been exploited as a valuable cell system which
carries the intrinsic capability of indefinite self-renewal and the potential to model the tissue-specific
physiology through the use of differentiation protocols to generate specific target cell/tissue types [12].
The tissue-specific differentiation of human ESCs and iPSCs has also been a valuable model to study
the early steps of human development. The acquisition of tissue-specific cell state by ESCs and
iPSCs through in vitro differentiation protocols follows a sequential activation of gene expression
program and epigenetic changes that closely mimic the developmental events occurring during early
embryogenesis [13–16].
The human iPSC differentiated NSCs have the transcriptional profile of dorsal neuroepithelium
(discussed in the results section), an early stage of brain development that gives rise to the majority of the
central nervous system, and therefore represents a relevant cell type to model early neurodevelopmental
and associated disorders [17]. To better understand the role of miRNA and mRNA interactions in
regulating iPSC to NSC differentiation as well as the role of such interactions in the maintenance
of neural stem cell state, in this manuscript, we have analyzed genome-wide miRNA and mRNA
sequencing data generated from iPSCs and their differentiated NSCs of six different individuals.
2. Results
2.1. Differentiation and Lineage-Specific Functional Characteristics of Generated NSCs
The NSC differentiation of validated iPSC lines, generated from six different individuals,
as described in our previous publications, Kumar et al. [18,19], were induced using the Gibco PSC
neural induction medium (Thermo Fisher Scientific, Waltham, MA, USA) and method as described in
Yan et al. [17], and summarized in the schematic presented in Figure 1A. An extensive characterization
of generated NSCs on day 14 (at passage P1) was performed using immunocytochemistry (ICC)
analysis of the NSC-specific markers and by genome-wide mRNA sequencing. The iPSC differentiated
NSCs expressed the NSC markers Nestin, PAX6, SOX1 and SOX2 across all six samples (Figure 1B).
The average correlation coefficient at 95% CI between six NSC samples, calculated based on all
expressed mRNAs, was 0.97 ± 0.008, suggesting a uniform differentiation of generated NSC lines
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Figure 2. Apical-basal polarity characteristic of iPSC-generated NSCs. (A) Epithelial cells
Figure 2. Apical-basal polarity characteristic of iPSC-generated NSCs. (A) Epithelial cells like
like localization of adherens junction’s protein N-cadherin in confluent NSC monolayer culture.
localization of adherens junction’s protein N-cadherin in confluent NSC monolayer culture. (B,C)
(B,C) Acquisition of radial apical basal property and N-cadherin localization in NSC monolayer
Acquisition of radial apical basal property and N-cadherin localization in NSC monolayer culture. (D,E)
culture. (D,E) Self-organization of differentiated NSCs into neural rosettes like structures in a 3D NSC
Self-organization of differentiated NSCs into neural rosettes like structures in a 3D NSC spheroid culture.
spheroid culture.
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2.3. In-Silico miRNA Target Prediction and Their Interaction with iPSC-NSC DE Transcriptome
Having established the DE miRNome and transcriptome between iPSCs and their differentiated
NSCs, next we sought to determine mRNA targets of the DE miRNAs that may play a regulatory
role in NSC differentiation of iPSCs and in early neural development. The miRNA target predictions
were performed using TargetScan-Human, TarBase and miRecords databases implemented in Qiagen
Ingenuity Pathway Analysis (IPA) platform release June 2020 (Qiagen, Redwood City, CA, USA).
The 51 miRNAs that were DE between iPSCs and their differentiated NSCs mapped to 39 mature
miRNA families, and 30 of these miRNA families, following the criteria that interaction sites were
either experimentally observed and/or predicted with high confidence, were predicted to target 3811
mRNAs, resulting in 4619 total miRNA-mRNA interactions. A total of 793 of these mRNA targets
were DE between iPSCs and their differentiated NSCs and resulted in 999 miRNA–mRNA interactions,
456 of these targets were oppositely expressed and resulted in 513 interactions between oppositely
expressed miRNA–mRNA pairs (Supplementary Materials Table S2). As per the IPA knowledge base,
about 10% of these interactions were experimentally observed in previous studies. About 40% of
these 513 miRNA–mRNA interactions were significantly enriched in organism development (209
mRNAs; FDR adjusted p-value range: 4.38 × 10−15 –1.52 × 10−4 ) and tissue development (204 mRNAs;
FDR adjusted p-value range: 8.06 × 10−15 –1.52 × 10−4 ) functional categories. About 30% interactions
were significantly enriched in nervous system development functions (154 mRNAs; FDR adjusted
p-value range: 8.06 × 10−15 –1.44 × 10−4 ). The significantly activated (activation z-score ≥ 1.5) nervous
system development functions listed in Table 1 suggest that miRNAs may play a significant regulatory
role in the nervous development and differentiation of iPSCs into NSCs.
Table 1. The nervous system development functions that were significantly enriched and predicted to
be upregulated in 513 miRNA–mRNA interactions identified in iPSCs and their differentiated NSCs.
Nervous System Development
Functions

Enrichment p-Value

Activation z-Score

Enriched
Interaction/mRNAs

Development of neurons
Formation of brain
Development of cerebral cortex
Formation of hippocampus
Neurogenesis of hippocampus
Neurogenesis of brain

8.06 × 10−15
5.94 × 10−10
1.63 × 10−6
2.43 × 10−6
2.78 × 10−5
4.09 × 10−5

2.074
1.841
1.969
1.941
2.219
2.102

70
44
17
13
6
8

The 85 mRNAs that were common between these significantly activated nervous system
development functions and their predicted interactions with DE miRNAs, shown in Figure 4,
have identified several regulatory networks which may play a key role in early neural development.
Overall, the upregulated miR-10a-5p, miR-30c-5p, miR-23-3p, miR-130a-3p and miR-17-5p miRNA
families were predicted to down-regulate genes that were involved in the specification and
differentiation of neurons, neurite outgrowth, synapse formation and neuronal maturation and
migration, as well as cellular death, suggesting that these upregulated miRNAs play a role in promoting
the self-renewal of undifferentiated NSCs (Figure 4). The downregulated miRNA families miR-291a-3p,
miR-200b-5p, miR-182-5p, miR-183-5p, miR-148a-3p, miR-193a-3p, miR-7704 and miR-7974 were
predicted to regulated several gene clusters involved in early neural induction of human ESCs and
iPSCs, cytoskeleton reorganization and axonal dynamics (Figure 4). Several other miRNA and mRNA
interactions inconsistent with the paradoxically opposite expression of miRNA and their targets were
also predicted, suggesting that DE miRNA may also play a role in finetuning the expression of such
targets in the maintenance of self-renewing NSCs.
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NSCs, were the predicted targets of eight upregulated miRNA families (miR-10a-5p, miR-30c-3p,
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Figure 5. miRNA–mRNA interactions enriched in human ESC pluripotency canonical pathways.

Wnt/β-catenin signaling: As indicated in the human ESC pluripotency pathway, the Wnt/β-catenin
Wnt/β-catenin signaling: As indicated in the human ESC pluripotency pathway, the
signaling genes were significantly enriched (p-value = 2.38 × 10−3 ) in the 513 miRNA–mRNA
interactions
Wnt/β-catenin signaling genes were significantly enriched (p-value = 2.38 × 10−3) in the 513
predicted between iPSC’s and NSC’s DE miRNome and transcriptome. The 11 interactions between
miRNA–mRNA interactions predicted between iPSC’s and NSC’s DE miRNome and transcriptome.
oppositely expressed 10 miRNA families and 10 DE mRNAs and several between unidirectionally
The 11 interactions between oppositely expressed 10 miRNA families and 10 DE mRNAs and several
expressed miRNA–mRNA pairs were enriched in the Wnt/β-catenin canonical pathway (Figure 6).
between unidirectionally expressed miRNA–mRNA pairs were enriched in the Wnt/β-catenin
The miRNA interactions of four Wnt/β-catenin signaling pathways genes WNT4, WNT5A, FZD3 and
canonical pathway (Figure 6). The miRNA interactions of four Wnt/β-catenin signaling pathways
LEF1, were discussed in the Human ESC pluripotency pathway above. The APC2 gene and the two
genes WNT4, WNT5A, FZD3 and LEF1, were discussed in the Human ESC pluripotency pathway
Wnt/β-catenin target genes CCND1 and KREMEN1 were predicted targets of four down-regulated
above. The APC2 gene and the two Wnt/β-catenin target genes CCND1 and KREMEN1 were
miRNA families (miR-291a-3p, miR-193a-3p, let-7 and miR-3648). Nuclear receptor genes NR5A2 and
predicted targets of four down-regulated miRNA families (miR-291a-3p, miR-193a-3p, let-7 and
RARG and gene GJA1 were down-regulated in NSCs and were the predicted targets of five up-regulated
miR-3648). Nuclear receptor genes NR5A2 and RARG and gene GJA1 were down-regulated in NSCs
miRNA families (miR-10a-5p, miR-532-5p, miR-30c-5p, miR-344a-5p and miR-130a-3p).
and were the predicted targets of five up-regulated miRNA families (miR-10a-5p, miR-532-5p,
miR-30c-5p, miR-344a-5p and miR-130a-3p).
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3. Discussion
3. Discussion
We have shown that the NSCs differentiated using the monolayer differentiation protocol and
We have shown that the NSCs differentiated using the monolayer differentiation protocol and
commercially available Gibco PSC neural induction medium (Thermo Fisher Scientific, Waltham, MA,
commercially available Gibco PSC neural induction medium (Thermo Fisher Scientific, Waltham,
USA), as described in Yan et al. [17], have the characteristics of dorsal neuroepithelium (Figure 1),
MA, USA), as described in Yan et al. [17], have the characteristics of dorsal neuroepithelium (Figure
an early stage of brain development that gives rise to the majority of the central nervous system,
1), an early stage of brain development that gives rise to the majority of the central nervous system,
and therefore represents a disease-relevant cell type whose production is scalable to a larger sample size
and therefore represents a disease-relevant cell type whose production is scalable to a larger sample
required to aid the discovery of molecular and neurodevelopmental changes and the identification of
size required to aid the discovery of molecular and neurodevelopmental changes and the
downstream genes or genetic variants influencing the human central nervous system development and
identification of downstream genes or genetic variants influencing the human central nervous
disease [12]. Furthermore, the differentiation of these iPSC-generated NSCs into other disease-relevant
system development and disease [12]. Furthermore, the differentiation of these iPSC-generated
neural lineage cell types, including cells of ventral neuroepithelium and terminally differentiated
NSCs into other disease-relevant neural lineage cell types, including cells of ventral neuroepithelium
neuron types, astrocytes and oligodendrocytes has been robustly demonstrated in our own work,
and terminally differentiated neuron types, astrocytes and oligodendrocytes has been robustly
as well as by others [17,18].
demonstrated in our own work, as well as by others [17,18].
The recent advancements in the capability of human ESC/iPSC differentiation strategies to
The recent advancements in the capability of human ESC/iPSC differentiation strategies to
recapitulate major hallmarks of in vivo neural development serve as a valuable resource for modelling
recapitulate major hallmarks of in vivo neural development serve as a valuable resource for
the development and disease of the human brain [17,22–26]. Furthermore, better understanding of the
modelling the development and disease of the human brain [17,22–26]. Furthermore, better
regulatory processes involved in differentiation and the regulatory role miRNAs may play in these
understanding of the regulatory processes involved in differentiation and the regulatory role
cellular transitions is critical to improve the in vitro modeling potential of these human ESC/iPSC
miRNAs may play in these cellular transitions is critical to improve the in vitro modeling potential
generated neural cells. However, due the heterogeneity and dynamic nature of the neural progeny,
of these human ESC/iPSC generated neural cells. However, due the heterogeneity and dynamic
both in in vivo neural development and the iPSC differentiated neural stem/progenitor cells, there is a
nature of the neural progeny, both in in vivo neural development and the iPSC differentiated neural
need to employ differentiation and a stage-specific strategy that allows investigation of these regulatory
stem/progenitor cells, there is a need to employ differentiation and a stage-specific strategy that
processes in a uniform NSC population [22,27]. For example, Edri et al. [27] identified five different
allows investigation of these regulatory processes in a uniform NSC population [22,27]. For example,
consecutive stages in the neural rosette-based differentiation of human ESC lines over a period of 220
Edri et al. [27] identified five different consecutive stages in the neural rosette-based differentiation
days of culture. Alternatively, a multipoint time course analysis may be important in identifying the
of human ESC lines over a period of 220 days of culture. Alternatively, a multipoint time course
stage-specific changes and regulatory interactions in neural rosette-based differentiation strategies
analysis may be important in identifying the stage-specific changes and regulatory interactions in
that produce more heterogeneous NSC and progenitor cell populations. Our iPSC-generated NSC
neural rosette-based differentiation strategies that produce more heterogeneous NSC and progenitor
expresses HES5, PAX6 and SOX1, along with other progenitor cell markers such as SOX2 and NESTIN
cell populations. Our iPSC-generated NSC expresses HES5, PAX6 and SOX1, along with other
progenitor cell markers such as SOX2 and NESTIN (Figure 1D, Table S1) and shares the expression
profile marking the establishment of the CNS earliest neuroepithelial cells [28]. The generated NSCs
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(Figure 1D, Table S1) and shares the expression profile marking the establishment of the CNS earliest
neuroepithelial cells [28]. The generated NSCs also showed the inherent property to self-organize
into radially arranged neural rosettes (Figure 2) and share a very uniform transcriptomic profile
across multiple samples (correlation coefficient at 95% CI = 0.97 ± 0.008). Therefore, in this study we
have primarily focused on the two well-defined timepoints of neural induction, the embryonic stem
cell stage, and the induction/establishment of the CNS earliest neuroepithelial cells, marked by our
well-characterized iPSCs and their differentiated NSCs, respectively.
Our differential expression analysis of the iPSCs and their differentiated NSCs expressed
miRNome and transcriptome identified 51 significantly DE miRNAs and 4033 significantly DE mRNAs.
As discussed in the results section, the transcriptomic and functional profile of our iPSC-generated
NSCs is consistent with the early neuroepithelial cells [17,27]. However the repertoire of 51 DE miRNA
between our iPSCs and their differentiated NSCs was smaller than a previous study [29], likely due to
some obvious differences in sample size [30,31], differentiation and miRNA typing methodologies and
plausibly due to the heterogeneity of the differentiated NSCs in [29], as discussed above. miR-9 and
miR-124a, which are known to be involved in differentiation of neural stem and progenitor cells into
neurons and astrocytes [3,32–35], were either not expressed or were expressed below the set expression
threshold (NRC < 20) in our NSCs. This further validates the naive neuroepithelial state, also referred
to as “primitive” in Yan et al., [17], of the NSCs generated by these methods.
The in silico prediction analysis of the iPSC’s and NSC’s DE miRNome and transcriptome identified
513 interactions between oppositely expressed 30 miRNA families (mapped to 51 DE miRNAs) and 456
DE mRNAs. These 513 predicted miRNA–mRNA interactions were highly enriched in nervous system
development functions and the 85 mRNAs common in the significantly activated nervous system
development functions (Table 1) and their predicted interactions with DE miRNAs shown in Figure 4
identified several regulatory networks. The upregulated miR-10a-5p miRNA family was the second
most abundant in our NSCs after miR-92a-3p and was predicted to regulate the expression of genes,
PRKCI whose down-regulation promotes NOTCH signaling and NSC self-renewal [36], pro-neural
genes RORB, BDNF and RNF112 [37–39], and HCN1 associated with differentiation of sympathetic
neurons [40]. miR-10a-5p along with miR-30c-5p and miR342-3p, was also predicted to down-regulate
the pro-apoptotic gene CASP3. These interactions suggest that the miR-10a-5p family of miRNAs
plays a significant role in regulating the self-renewal of undifferentiated NSCs. Similarly, the miRNA
families miR-30c-5p, miR23-3p, miR130a-3p and miR-17-5p were predicted to down-regulate genes
(Figure 4) involved in the neural specification and differentiation of neurons, neurite outgrowth, synapse
formation, and therefore play a role in regulating the differentiation of NSCs [41]. The down-regulated
miRNA families miR-291a-3p, miR-548o-3p, miR-7974, miR-183-5p, miR-182-5p, and miR-7704 were
predicted to target Wnt/β-catenin associated genes. The up-regulation of the Wnt/β-catenin signaling
pathway in NSCs and its down regulation upon neuron differentiation suggests that this pathway
may play a role in the self-renewal of undifferentiated NSCs [42]. The BMP signaling inhibitors NOG
and ZEB2 were the predicted targets of down-regulated miR-148a-3p, miR-200b-3p and miR-183-5p
miRNA families. The E-cadherin suppressor ZEB controls the E-cadherin to N-cadherin switch and
thus stabilizes N-cadherin-based adherens junctions, which play a critical role in the self-renewal of
undifferentiated NSCs [43,44].
4. Materials and Methods
The six iPSC lines used in this study were previously reprogrammed from lymphoblastoid cells
lines established in-vitro using blood samples of our San Antonio Mexican American Family Study
(SAMAFS) participants, who were originally recruited in our San Antonio Family Heart Study (SAFHS),
and provided appropriate written consent. The study protocols were approved by the Institutional
Review Boards of UT Health San Antonio (HSC20060194H, 16 March 2020) and the University of Texas
Rio Grande Valley, Edinburg (IRB-18-0245, 16 March 2020).
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4.1. NSC Differentiation
A detailed description of iPSC reprogramming and validation methodology used in
reprogramming of six iPSC lines and their validation can found in our previous publications [18,19].
The NSC differentiation was induced using commercially available Gibco PSC neural induction
medium (Thermo Fisher Scientific, Waltham, MA, USA) and the method as described in Yan et al. [17].
Briefly, iPSCs maintained in feeder-free conditions were split as cell clumps in a Geltrex (Thermo
Fisher Scientific, Waltham, MA, USA) coated, six-well plate at a density reaching 15–25% confluence
after 24 h and maintained in mTeSR-1 medium (Stem Cell Technologies Inc., Cambridge, MA, USA)
supplemented with 10 µM ROCK inhibitor Y27632 (ATCC, Manassas, VA, USA). Approximately
24 h after splitting, culture medium was switched to Gibco PSC Neural Induction Medium (Thermo
Fisher Scientific, Waltham, MA, USA). Medium was changed every other day. On day 7, NSCs were
dissociated with Stem Pro Accutase (Thermo Fisher Scientific, Waltham, MA, USA) and plated on
a Geltrex-coated plate at a density of 1 × 105 cells/cm2 in an NSC expansion medium containing
50% Neurobasal medium, 50% Advanced DMEM/F12, and 1X neural induction supplement (all from
Thermo Fisher Scientific, Waltham, MA, USA). The NSC expansion medium was supplemented with
5 µM ROCK inhibitor Y27632 (ATCC, Manassas, VA, USA) for first 24 h. NSC expansion medium was
changed every other day until NSCs reached confluence. The six generated NSC lines from passage
one were used for characterization and total RNA extraction.
4.2. ICC-Based Characterization and Apical-Basal Polarity Assay of Generated NSCs
For ICC-based characterization of the iPSC-differentiated NSCs, the cultured NSCs from passage
one were fixed using 4% paraformaldehyde (MilliporeSigma, St. Louis, MO, USA) and then
immunoassayed using commercially available primary antibodies against NSC specific markers
Nestin (Thermo Fisher Scientific, Waltham, MA, USA), PAX6 (Cell Signaling Technology, Inc., Danvers,
MA, USA), SOX1 (Thermo Fisher Scientific, Waltham, MA, USA) and SOX2 (Cell Signaling Technology,
Inc., Danvers, MA, USA), and standard ICC techniques.
For apical-basal polarity assays in monolayer culture, the passage one NSCs were plated on a
Geltrex-coated plate at a density of 1 × 105 cells/cm2 in the NSC expansion medium supplemented
with 5 µM ROCK inhibitor Y27632 (ATCC, Manassas, VA, USA) for the first 24 h and then cultured
into NSC expansion medium without ROCK inhibitor for the next 24 h. At 48 h, NSC monolayer
cultures were fixed with 4% paraformaldehyde (MilliporeSigma, St. Louis, MO, USA) and then
immunoassayed using commercially available primary antibodies against adherens junction protein
N-cadherin (Thermo Fisher Scientific, Waltham, MA, USA).
For apical-basal polarity assays in 3D NSC spheroids, 3D NSC spheroids were generated
from passage one NSCs (4000 NSCs/spheroid) in an AggreWell 800 plate (Stem Cell Technologies
Inc., Cambridge, MA, USA) and maintained in NSC expansion medium for 24 h. After 24 h,
the generated 3D spheroids were harvested and plated on laminin-coated plates in an NSC
expansion medium. After 120 h, the cultures were fixed with 4% paraformaldehyde (Sigma Aldrich)
and then immunoassayed using anti N-cadherin (Thermo Fisher Scientific, Waltham, MA, USA)
primary antibodies.
In each assay, cells were counterstained with 40 ,6-Diamidino-2-phenylindole dihydrochloride
(DAPI) nuclear stain (MilliporeSigma, St. Louis, MO, USA) and were imaged on a Carl Zeiss
epifluorescence equipped inverted microscope (Carl Zeiss Microscopy, LLC, White Plains, NY, USA).
4.3. RNA Extraction and Sequencing
Total RNA extraction and small RNA and mRNA sequencing of the six validated reprogrammed
iPSCs were performed previously and described in our previous publication [19].
Total RNA extraction: The total RNA from snape frozen cell pellets (~3–5 × 106 cells) from six
iPSC differentiated passage one NSCs was extracted using commercially available RNeasy Mini Kit
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(Qiagen, Germantown, MD, USA) and the manufacturer protocol. RNA quality and quantity were
assessed using a NanoDrop 2000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA)
and an Agilent 2200 TapeStation system (Agilent, Santa Clara, CA, USA).
Small RNA Sequencing: Small RNA sequencing libraries were prepared from 1 µg total RNA per
sample and using an Illumina TruSeq small RNA sample preparation kit (Illumina, Inc., San Diego, CA,
USA). The kit uses a modified RNA 3’ adaptor that specifically targets miRNA and other small RNAs
that have a 3’ hydroxyl group. After adaptor ligation to each end, reverse transcription was performed
to synthesize complementary single stranded cDNA. The cDNA libraries were then PCR-amplified
and gel-purified for a fragment size of 145–160 nucleotides. The size-selected purified cDNA libraries
from six NSC samples were then sequenced using the Illumina HiSeq 2500 platform (Illumina, Inc.,
San Diego, CA, USA).
mRNA Sequencing: The 1 µg total RNA per sample, extracted from six, passage one NSC lines
and Illumina TruSeq RNA sample preparation kit v2 (Illumina, Inc., San Diego, CA, USA), was used
to prepared mRNA sequencing libraries. Briefly, the poly-A tail containing mRNA molecules was
enriched from total RNA using oligo dT attached magnetic beads. The mRNA-enriched samples
were then fragmented into ~200–600 base pair fragments using divalent cations under elevated
temperature. The cleaved RNA fragments were used as a template to synthesize first-strand cDNA using
reverse transcriptase and random primers, followed by second-strand cDNA synthesis, using DNA
polymerase-I and RNase H. The synthesized cDNA fragments were then end-repaired, and adaptor
ligations were performed. The end-repaired, and adaptor-ligated cDNA libraries were then purified and
enriched by PCR before deep sequencing on Illumina HiSeq 2500 platform (Illumina, Inc., San Diego,
CA, USA).
Sequence Analysis: Raw fastq sequence files were generated and demultiplexed using Illumina
CASAVA v1.8 pipeline (Illumina, Inc., San Diego, CA, USA). After pre-alignment QCs, sequences
were aligned to human genome assembly GRCh38 (hg38) and mapped to RefSeq transcripts using
StrandNGS software v3.3 (Strand Life Sciences Pvt. Ltd., Bangalore, India). Small RNA reads were
mapped to small RNA annotations inferred from miRbase (v20), ensemble (e75), gtrnadb (tRNA) and
UCSC know Gene tables (piRNA) and implemented in Strand NGS software. The aligned reads were
filtered based on default read quality matrix and log transformation and “DESeq” normalization were
applied. The known miRNAs and mRNAs having an NRC ≥20 in six iPSCs and/or their differentiated
NSCs were considered expressed and selected for differential gene expression analysis.
4.4. Differential Gene Expression and In-Silico miRNA Target Prediction Analyses
miRNA and mRNA DE analysis: To identify DE miRNAs and mRNAs, moderated t statistics and
expression fold change analyses were performed on miRNA and mRNA data sets. The miRNAs and
mRNAs having moderated t statistic FDR corrected p-value ≤ 0.05 and FC-abs ≥ 2.0, were considered DE.
miRNA target prediction analysis: The miRNA target prediction analysis was performed using
TargetScan-Human, TarBase and miRecords databases as implemented in the Qiagen IPA platform
(Qiagen, Redwood City, CA, USA). The TargetScan content in IPA uses TargetScan algorithm-predicted
mRNA targets of human miRNAs that are binned into high and moderate confidence. TarBase
content identifies experimentally demonstrated miRNA–mRNA interactions from TarBase using
miRbase identifiers, and miRecords content uses experimentally validated human, rat, and mouse
miRNA-mRNA interactions from the published literature. The mRNA targets predicted with high
confidence and experimentally observed mRNA targets from TarBase and miRecords that were
significantly DE between iPSCs and their differentiated NSCs and showed paradoxical opposite
expression from interacting miRNA(s) were considered for functional analysis.
Functional annotation and gene expression analysis: Functional annotations and pathway analysis
were performed using identified miRNA–mRNA interactions between oppositely expressed miRNA
and mRNAs and IPA platform. Right-tailed Fisher’s exact test p values corrected for FDR were used
to calculate enrichment significance. The direction of functional change was assessed by activation
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Z-score, as implemented in IPA. Further details of the methods implemented in IPA can be found
in [45].
5. Conclusions
In conclusion, we have identified 51 miRNAs and 4033 mRNAs that were significantly DE
between iPSCs and their differentiated NSCs. We have also identified 513 miRNA-mRNA interactions
predicted with high confidence between oppositely expressed 30 miRNA families (mapped to 51
DE miRNAs) and 456 DE mRNAs. These 513 interactions were highly enriched in nervous system
development functions, suggesting that they may play a key role in regulating early brain development
and in the differentiation and maintenance of iPSC-generated NSCs. However, further functional
studies are necessary to validate these predicted and potentially regulatory miRNA and mRNA
interactions. This study also provides a comprehensive characterization of iPSC-generated NSCs
as dorsal neuroepithelium, important for their potential use in in vitro modeling of human brain
development and disease.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/21/19/
6980/s1.
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